Vertaling van "long-term data from a pivotal fracture " (Nederlands → Frans) :

Reinforcing its efficacy and safety profile, new long-term data from a pivotal fracture trial show Aclasta preserved bone mass in patients who received annual infusions for six years and the risk of new morphometric spine fractures was reduced by 52% when measured as a secondary endpoint compared to those who stopped treatment at three years.
Renforçant son profil d’efficacité et d’innocuité, de nouveaux résultats provenant d’un essai pivot de long terme sur les fractures montrent que Reclast/Aclasta conserve la masse osseuse de malades qui ont reçu une perfusion annuelle pendant six ans. En outre, le risque de nouvelles fractures morphométriques de la colonne vertébrale, mesuré en tant que critère secondaire, a été réduit de 52% par rapport aux malades qui ont arrêté le traitement au bout de trois ans.

The US prescribing information for Femara was updated to include long-term (73- month) follow-up data from the BIG 1-98 study comparing Femara with tamoxifen in the initial adjuvant setting.
Aux Etats-Unis, les informations concernant la prescription de Femara a été mise à jour de manière à intégrer les données récoltées sur une longue période (73 mois) provenant de l’étude BIG 1-98 comparant Femara avec le tamoxifène comme traitement adjuvant de première intention.

Data from a one-year Phase III trial published in “The New England Journal of Medicine” in June confirmed that Ilaris offered rapid and long-term clinical remission in CAPS patients.
Des données d’un essai de phase III sur un an publiées en juin dans «The New England Journal of Medicine» ont confirmé qu’Ilaris offrait une rémission clinique rapide et de longue durée des CAPS.

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).